When examining the pathological characteristics, Horisawa et al. reviewed 4007 HER2-0 and HER2-low patients and reported that HER2-low breast cancer had a lower T stage and a lower HG compared to HER2-0 breast cancer [16]. The gene discussed is ERBB2; the disease is breast carcinoma.